Purpose Managing hip fracture surgery in patients taking clopidogrel is challenging. The
optimal timing for surgery remains unclear. Early surgery in such patients potentially …

Objective: Timing of surgery in hip fracture patients using antiplatelet agents is a
controversial issue. Clopidogrel is an antiplatelet drug widely used in the treatment of many …

Materials and Methods A retrospective, case control study chart review over a five year span
was conducted. Of the 2,766 geriatric hip fracture patients surgically treated, 52 patients …

It remains unclear whether it is justifiable to delay hip fracture surgery in patients who are
taking clopidogrel therapy–—to allow the drug's anti-platelet effect to wear off. In a follow-up …

Purpose. To compare morbidity and mortality after hip fracture surgery in patients
withholding clopidogrel for 3 to 6 days versus≥ 7 days. Methods. Records of 16 men and 31 …

Introduction Hip fracture is a common presentation in the elderly population, many of whom
will be taking the antiplatelet clopidogrel, which has the potential to increase perioperative …

Introduction: Clopidogrel is a potent oral antiplatelet agent that is commonly prescribed to
patients with cardiovascular disease. Patients presenting with proximal femoral fractures …

Objective To compare postoperative outcomes of hip fracture surgery in patients who were
and were not taking clopidogrel at the time of surgery. Patients and Methods Using the …

Patients taking clopidogrel who sustain a fractured neck of femur pose a challenge to
orthopaedic surgeons. The aim of this study was to determine whether delay to theatre for …

Over 76,000 patients in the UK sustain a proximal femoral fracture. Clopidogrel is currently
the world's second best selling drug. There has been much recent controversy surrounding …